Literature DB >> 18313290

Epidemiology of viral hepatitis infections in an area of southern Italy with high incidence rates of liver cancer.

Mario Fusco1, Enrico Girardi, Pierluca Piselli, Raffaele Palombino, Jerry Polesel, Carmela Maione, Paola Scognamiglio, Francesco Aurelio Pisanti, Mariacarmela Solmone, Pietro Di Cicco, Giuseppe Ippolito, Silvia Franceschi, Diego Serraino.   

Abstract

Southern Italy shows the highest rates of liver cancer for Europe, mainly related to infection with hepatitis viruses. We thus described incidence rates of liver cancer and investigated prevalence and determinants of HCV and HBV infections in 4496 individuals randomly selected from the general population of the province of Naples. 7.5% was infected with HCV and 27.6% with HBV (2.2% was HBsAg-positive). Prevalence of both infections increased with age, 23.2% of those aged 65 years or older was HCV-positive and 47.9% were HBV-positive. Intravenous drug use (odds ratio (OR)=16.4 for anti-HCV and 4.7 for anti-HBc), history of blood transfusions (OR=2.8 and 1.5, respectively) and surgery, and household contacts with infected people (OR=2.1 and 1.6, respectively) increased risks for both infections. Sexual intercourse with HCV-positive individuals conveyed a 3-fold higher risk of HCV infection. This study quantified the spread of HCV and HBV in the population of southern Italy heavily affected by liver cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18313290     DOI: 10.1016/j.ejca.2008.01.025

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  19 in total

Review 1.  Health care-associated hepatitis C virus infection.

Authors:  Bruno Pozzetto; Meriam Memmi; Olivier Garraud; Xavier Roblin; Philippe Berthelot
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

2.  A possible predictive marker of progression for hepatocellular carcinoma.

Authors:  Michele DI Stasio; Maria Grazia Volpe; Giovanni Colonna; Melissa Nazzaro; Miriam Polimeno; Stefania Scala; Giuseppe Castello; Susan Costantini
Journal:  Oncol Lett       Date:  2011-08-09       Impact factor: 2.967

Review 3.  Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment.

Authors:  Giuseppe Castello; Susan Costantini; Stefania Scala
Journal:  J Transl Med       Date:  2010-11-03       Impact factor: 5.531

4.  TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients.

Authors:  Valeria Di Vuolo; Luigi Buonaguro; Francesco Izzo; Simona Losito; Gerardo Botti; Franco M Buonaguro; Maria Lina Tornesello
Journal:  Infect Agent Cancer       Date:  2011-08-15       Impact factor: 2.965

5.  The XIX century smallpox prevention in Naples and the risk of transmission of human blood-related pathogens.

Authors:  Franco Maria Buonaguro; Maria Lina Tornesello; Luigi Buonaguro
Journal:  J Transl Med       Date:  2015-01-27       Impact factor: 5.531

6.  Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma.

Authors:  Valeria De Giorgi; Alessandro Monaco; Andrea Worchech; Marialina Tornesello; Francesco Izzo; Luigi Buonaguro; Francesco M Marincola; Ena Wang; Franco M Buonaguro
Journal:  J Transl Med       Date:  2009-10-12       Impact factor: 5.531

7.  Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy.

Authors:  Paola Scognamiglio; Enrico Girardi; Mario Fusco; Pierluca Piselli; Silvana Russo Spena; Carmela Maione; Francesco Aurelio Pisanti; Diego Serraino
Journal:  BMC Infect Dis       Date:  2009-06-07       Impact factor: 3.090

8.  Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy.

Authors:  Pierluca Piselli; Diego Serraino; Mario Fusco; Enrico Girardi; Angelo Pirozzi; Federica Toffolutti; Claudia Cimaglia; Martina Taborelli
Journal:  BMC Infect Dis       Date:  2021-07-08       Impact factor: 3.090

9.  Cytokinome profile of patients with type 2 diabetes and/or chronic hepatitis C infection.

Authors:  Susan Costantini; Francesca Capone; Eliana Guerriero; Raffaele Marfella; Angela Sorice; Patrizia Maio; Michele Di Stasio; Giuseppe Paolisso; Giuseppe Castello; Giovanni Colonna
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

10.  Clinical oncology in resource-limited settings.

Authors:  Franco M Buonaguro; Serigne N Gueye; Henry R Wabinga; Twalib A Ngoma; Jan B Vermorken; Sam M Mbulaiteye
Journal:  Infect Agent Cancer       Date:  2013-10-07       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.